{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:15:55Z","timestamp":1791375355035,"version":"4.3.1"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T00:00:00Z","timestamp":1287446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Hydroxycarbamide (HC) is a pharmacological agent capable of stimulating fetal haemoglobin (HbF) production during adult life. High levels of HbF may ameliorate the clinical course of \u03b2\u2010thalassaemia and sickle cell disease. The efficacy of HC for the treatment of thalassaemia major and thalassaemia intermedia is variable. Although an increase of HbF has been observed in most patients, only some patients experience significant improvement in total haemoglobin levels. This study aimed to determine the effectiveness and safety of short\u2010 (1\u2003year) and long\u2010term (mean follow\u2010up 68\u2003months) HC treatment in 24 thalassaemia intermedia patients. Additionally, we evaluated if primary erythroid progenitor cells cultured from treated patients responded to HC treatment in a manner similar to that observed <jats:italic>in vivo<\/jats:italic>. Our results confirm a good response to HC after a short\u2010term follow\u2010up in 70% of thalassaemia intermedia patients and a reduction of clinical response in patients with a long follow\u2010up. Erythroid cultures obtained from patients during treatment reproduced the observed <jats:italic>in vivo<\/jats:italic> response. Interestingly, haematopoietic stem cells from long\u2010term treated patients showed reduced ability to develop into primary erythroid cultures some months before the reduction of the \u2018<jats:italic>in vivo<\/jats:italic>\u2019 response. The mechanism of this loss of response to HC remains to be determined.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2010.08397.x","type":"journal-article","created":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T11:28:22Z","timestamp":1287487702000},"page":"509-515","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Desensitization to hydroxycarbamide following long\u2010term treatment of thalassaemia intermedia as observed <i>in vivo<\/i> and in primary erythroid cultures from treated patients"],"prefix":"10.1111","volume":"151","author":[{"given":"Paolo","family":"Rigano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Pecoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Calzolari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Troia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santina","family":"Acuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disma","family":"Renda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano Restivo","family":"Pantalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Maggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba Di","family":"Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,19]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703273361318"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(01)90031-9"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01399.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07041.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.10.2555.2555"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200316672"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2005.07.014"},{"key":"e_1_2_6_9_1","first-page":"61","article-title":"Hydroxyurea induction of fetal hemoglobin synthesis in sickle cell disease","volume":"19","author":"Dover G.J.","year":"1992","journal-title":"Seminars in Oncology"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/08880010903271671"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1345.029"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood.V81.6.1630.1630","article-title":"Hydroxyurea increases fetal hemoglobin in cutured erythroid cells derived from normal individuals and patients with sickle cell anemia or \u03b2\u2010thalassemia","volume":"81","author":"Fibach E.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","first-page":"23915","DOI":"10.1016\/S0021-9258(20)80472-4","article-title":"Cooperation of GATA\u20101 and Sp\u20101 can result in synergistic transcriptional activation or interference","volume":"268","author":"Fischer K.D.","year":"1993","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood.V87.3.887.bloodjournal873887","article-title":"Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in \u03b2\u2010thalassemia\/hemoglobin E disease","volume":"87","author":"Fucharoen S.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.62020496.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-2607(96)01720-8"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<221::AID-AJH4>3.0.CO;2-R"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.14.9489"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2009.06.019"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.3109\/08880011003639952"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb10469.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.1.239.239"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06002.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.22.9000"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63080-2"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.3109\/03630269708997382"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1182\/blood.V84.11.3929.bloodjournal84113929","article-title":"Augmentation of gamma\u2010globin gene promoter activity by carboxylic acids and components of the human beta\u2010globin locus control region","volume":"84","author":"Safaya S.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_28_1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V95.3.863.003k12_863_869","article-title":"Quantitative PCR analysis of HbF inducers in primary human adult erythroid cells","volume":"95","author":"Smith R.D.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21699"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-243154"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-221333"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.47.33190"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2005.09.006"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2010.08397.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2010.08397.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:49:47Z","timestamp":1697424587000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2010.08397.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,19]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1111\/j.1365-2141.2010.08397.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08397.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,19]]},"assertion":[{"value":"2010-10-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}